Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Immunological Reviews|August 7, 2023
Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitisFiamma Berner, Lukas FlatzEuropean Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitorsOmar Hasan Ali, Fiamma Berner, David Bomze, et al.Cancer Management and Research|December 7, 2018
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatmentStefan Diem, Mirjam Fässler, Omar Hasan Ali, et al.Cancer Immunology, Immunotherapy : CII|August 18, 2020
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patientsOmar Hasan Ali, Fiamma Berner, Christoph Jakob Ackermann, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor TreatmentStefan Diem, Mirjam Fässler, David Bomze, et al.The Journal of Cell Biology|April 9, 2017
Defects in ER-endosome contacts impact lysosome function in hereditary spastic paraplegiaRachel Allison, James R Edgar, Guy Pearson, et al.Journal for Immunotherapy of Cancer|March 16, 2022
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancerNiklas Klümper, Jonas Saal, Fiamma Berner, et al.Journal of Cancer Research and Clinical Oncology|December 7, 2021
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patientsMette-Triin Purde, Rebekka Niederer, Nikolaus B Wagner, et al.Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.Cancer Discovery|May 20, 2021
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with CancerTatjana Bilich, Malte Roerden, Yacine Maringer, et al.Pageof 2